Growing community of inventors

Doylestown, PA, United States of America

Amy Sasser

Average Co-Inventor Count = 5.14

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 40

Amy SasserParul Doshi (4 patents)Amy SasserTahamtan Ahmadi (2 patents)Amy SasserRaymond Comenzo (2 patents)Amy SasserXun Ma (2 patents)Amy SasserChakra Chaulagain (2 patents)Amy SasserGwenn Danet-Desnoyers (2 patents)Amy SasserCedric Dos Santos (2 patents)Amy SasserXiaochuan Shan (2 patents)Amy SasserNiels Van De Donk (1 patent)Amy SasserHenk Lokhorst (1 patent)Amy SasserTuna Mutis (1 patent)Amy SasserChristopher Chiu (1 patent)Amy SasserTineke Casneuf (1 patent)Amy SasserMing Qi (1 patent)Amy SasserJordan Schecter (1 patent)Amy SasserTineke Casneuf (0 patent)Amy SasserHenk M Lokhorst (0 patent)Amy SasserAmy Sasser (6 patents)Parul DoshiParul Doshi (11 patents)Tahamtan AhmadiTahamtan Ahmadi (8 patents)Raymond ComenzoRaymond Comenzo (3 patents)Xun MaXun Ma (3 patents)Chakra ChaulagainChakra Chaulagain (2 patents)Gwenn Danet-DesnoyersGwenn Danet-Desnoyers (2 patents)Cedric Dos SantosCedric Dos Santos (2 patents)Xiaochuan ShanXiaochuan Shan (2 patents)Niels Van De DonkNiels Van De Donk (4 patents)Henk LokhorstHenk Lokhorst (3 patents)Tuna MutisTuna Mutis (3 patents)Christopher ChiuChristopher Chiu (2 patents)Tineke CasneufTineke Casneuf (1 patent)Ming QiMing Qi (1 patent)Jordan SchecterJordan Schecter (1 patent)Tineke CasneufTineke Casneuf (0 patent)Henk M LokhorstHenk M Lokhorst (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Biotech, Inc. (6 from 410 patents)

2. Tufts University (2 from 704 patents)


6 patents:

1. 12286474 - Anti-CD38 antibodies for treatment of acute myeloid leukemia

2. 12091466 - Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies

3. 11618787 - Methods of treating high risk multiple myeloma

4. 11021543 - Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38

5. 10793630 - Anti-CD38 antibodies for treatment of acute myeloid leukemia

6. 10766965 - Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…